| scholarly article | Q13442814 |
| P2093 | author name string | Walter Birchmeier | |
| Jane D Holland | |||
| Ulrike Ziebold | |||
| Peter Wend | |||
| P2860 | cites work | Telomerase modulates Wnt signalling by association with target gene chromatin | Q24310084 |
| P433 | issue | 8 | |
| P921 | main subject | neoplastic stem cells | Q1638475 |
| P304 | page(s) | 855-863 | |
| P577 | publication date | 2010-09-15 | |
| P1433 | published in | Seminars in Cell & Developmental Biology | Q14330411 |
| P1476 | title | Wnt signaling in stem and cancer stem cells | |
| P478 | volume | 21 |
| Q35056183 | 17β-Estradiol induces supernumerary primordial germ cells in embryos of the polychaete Platynereis dumerilii |
| Q42152874 | A critical role for the Wnt effector Tcf4 in adult intestinal homeostatic self-renewal |
| Q37407566 | Activation of the Wnt pathway through AR79, a GSK3β inhibitor, promotes prostate cancer growth in soft tissue and bone |
| Q90700674 | Aglycone Polyether Nanchangmycin and Its Homologues Exhibit Apoptotic and Antiproliferative Activities against Cancer Stem Cells |
| Q36608494 | An analysis of cyclin D1, cytokeratin 5/6 and cytokeratin 8/18 expression in breast papillomas and papillary carcinomas |
| Q39214227 | Anti-Cancer Phytometabolites Targeting Cancer Stem Cells |
| Q38939530 | BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10. |
| Q38941719 | Bone regeneration in the stem cell era: safe play for the patient? |
| Q37640678 | Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice |
| Q38270188 | Caenorhabditis elegans: A Model System for Anti-Cancer Drug Discovery and Therapeutic Target Identification |
| Q38007261 | Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links |
| Q38965946 | Cancer stem cells: A product of clonal evolution? |
| Q36602083 | Canonical WNT signaling regulates development of bovine embryos to the blastocyst stage |
| Q34431614 | Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma |
| Q33704244 | Characterization of microRNAs expression profiles in human dental-derived pluripotent stem cells. |
| Q38409303 | Consumption of Red/Processed Meat and Colorectal Carcinoma: Possible Mechanisms Underlying the Significant Association |
| Q59135088 | Decreased expression of peroxiredoxin1 inhibits proliferation, invasion, and metastasis of ovarian cancer cell |
| Q54294158 | Differential gene expression of Wnt signaling pathway in benign, premalignant, and malignant human breast epithelial cells. |
| Q38112122 | Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer |
| Q35098085 | Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment |
| Q36010008 | Down's-syndrome-related kinase Dyrk1A modulates the p120-catenin-Kaiso trajectory of the Wnt signaling pathway |
| Q37722174 | Effects of S100A6 gene silencing on the biological features of eutopic endometrial stromal cells and β‑catenin expression |
| Q53139818 | Endometriotic mesenchymal stem cells significantly promote fibrogenesis in ovarian endometrioma through the Wnt/β-catenin pathway by paracrine production of TGF-β1 and Wnt1. |
| Q38014664 | EpCAM and its potential role in tumor-initiating cells |
| Q26801710 | Evolutionary determinants of cancer |
| Q33688716 | Expression and functional regulation of stemness gene Lgr5 in esophageal squamous cell carcinoma |
| Q40843427 | Expression of Wnt9, TCTP, and Bmp1/Tll in sea cucumber visceral regeneration. |
| Q35273654 | FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells. |
| Q50105646 | FoxM1 and β-catenin predicts aggressiveness in Middle Eastern ovarian cancer and their co-targeting impairs the growth of ovarian cancer cells. |
| Q45912883 | Frizzled 8 promotes the cell proliferation and metastasis of renal cell carcinoma. |
| Q58197289 | Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer |
| Q37982704 | GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder |
| Q35741579 | Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin |
| Q38650987 | Gene expression profiling analysis contributes to understanding the association between non-syndromic cleft lip and palate, and cancer |
| Q42366558 | Heparin antagonizes cisplatin resistance of A2780 ovarian cancer cells by affecting the Wnt signaling pathway |
| Q37882048 | How do they do Wnt they do?: regulation of transcription by the Wnt/β-catenin pathway. |
| Q53090074 | Hyaluronic acid enhances proliferation of human amniotic mesenchymal stem cells through activation of Wnt/β-catenin signaling pathway. |
| Q34513657 | Hypoxia-inducible factors modulate the stemness and malignancy of colon cancer cells by playing opposite roles in canonical Wnt signaling |
| Q50050335 | Impact of Altered WNT2B Expression on Bladder Wall Fibroblasts: Implications for Apoptosis Regulation in the Stroma of the Lower Urinary Tract. |
| Q34692280 | In vitro effects of a small-molecule antagonist of the Tcf/ß-catenin complex on endometrial and endometriotic cells of patients with endometriosis |
| Q39003793 | Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer. |
| Q30505741 | Inhibition of heart formation by lithium is an indirect result of the disruption of tissue organization within the embryo |
| Q47162378 | Inhibition of porcupine prolongs metastasis free survival in a mouse xenograft model of Ewing sarcoma |
| Q53120403 | Intestinal knockout of Nedd4 enhances growth of Apcmin tumors. |
| Q35017079 | Involvement of the Wnt/β-catenin signaling pathway in the cellular and molecular mechanisms of fibrosis in endometriosis |
| Q42261483 | LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer |
| Q34619246 | LGR5 promotes the proliferation and tumor formation of cervical cancer cells through the Wnt/β-catenin signaling pathway |
| Q38812867 | Lapatinib resistance in HER2+ cancers: latest findings and new concepts on molecular mechanisms |
| Q24635897 | Maintaining embryonic stem cell pluripotency with Wnt signaling |
| Q26740086 | Mammary Development and Breast Cancer: A Wnt Perspective |
| Q24629797 | Mammary gland development |
| Q35243349 | Mesd is a general inhibitor of different Wnt ligands in Wnt/LRP signaling and inhibits PC-3 tumor growth in vivo |
| Q34675280 | MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. |
| Q41880162 | Molecular and cellular features of murine craniofacial and trunk neural crest cells as stem cell-like cells. |
| Q42251960 | Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions |
| Q35238287 | Mouse mammary stem cells express prognostic markers for triple-negative breast cancer |
| Q38953085 | Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this? |
| Q37012394 | N-glycosylation induces the CTHRC1 protein and drives oral cancer cell migration |
| Q41478957 | Neuropilin-1 is upregulated by Wnt/β-catenin signaling and is important for mammary stem cells |
| Q28478466 | Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway |
| Q27324745 | Non-Darwinian dynamics in therapy-induced cancer drug resistance |
| Q36739388 | Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas |
| Q42740079 | Ontogeny and Homeostasis of Adult Epithelial Skin Stem Cells |
| Q37947084 | Phosphoproteomic analysis: an emerging role in deciphering cellular signaling in human embryonic stem cells and their differentiated derivatives |
| Q37301034 | Postnatal isoform switch and protein localization of LEF1 and TCF7L2 transcription factors in cortical, thalamic, and mesencephalic regions of the adult mouse brain |
| Q57153312 | Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma |
| Q26861795 | Protein N-glycosylation in oral cancer: dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signaling |
| Q34383397 | Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites |
| Q91651955 | Role of Wnt/β-Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer |
| Q21285139 | Salinomycin as a drug for targeting human cancer stem cells |
| Q38023902 | Sclerostin: a possible target for the management of cancer-induced bone disease |
| Q38137811 | Stem cells and aging from a quasi-immortal point of view |
| Q35679028 | Systematically dissecting the global mechanism of miRNA functions in mouse pluripotent stem cells |
| Q38254685 | TCF/Lef1 activity controls establishment of diverse stem and progenitor cell compartments in mouse epidermis |
| Q37978193 | Targeting MET in cancer: rationale and progress |
| Q49544368 | Targeting Stemness: Implications for Precision Medicine in Breast Cancer. |
| Q42558443 | Targeting Wnt pathway in mantle cell lymphoma-initiating cells. |
| Q64937696 | Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma. |
| Q35673625 | Targeting the Wnt/β-catenin pathway in endometriosis: a potentially effective approach for treatment and prevention |
| Q34504817 | Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974. |
| Q38152532 | The Wnt/β-catenin pathway in ovarian cancer: a review. |
| Q36674940 | The Wnt/β-catenin signaling/Id2 cascade mediates the effects of hypoxia on the hierarchy of colorectal-cancer stem cells |
| Q37859090 | The role of WNT10B in physiology and disease |
| Q38939378 | The soft agar colony formation assay |
| Q26777880 | Therapies targeting cancer stem cells: Current trends and future challenges |
| Q35038884 | Thyroid-specific transcription factors and their roles in thyroid cancer |
| Q36490298 | Trichosanthin suppresses the proliferation of glioma cells by inhibiting LGR5 expression and the Wnt/β-catenin signaling pathway |
| Q34914935 | Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas |
| Q42142034 | WIF-1 gene inhibition and Wnt signal transduction pathway activation in NSCLC tumorigenesis |
| Q34456446 | WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway |
| Q36602135 | WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer |
| Q33857980 | Winning WNT: race to Wnt signaling inhibitors |
| Q39306017 | Wnt Signaling in Normal and Malignant Stem Cells |
| Q34658275 | Wnt signaling and the control of human stem cell fate. |
| Q36329477 | Wnt signaling in mammary glands: plastic cell fates and combinatorial signaling |
| Q35674844 | Wnt/β-Catenin Signaling Pathway in Skin Carcinogenesis and Therapy. |
| Q37132716 | Wnt/β-catenin Signaling in Normal and Cancer Stem Cells. |
| Q38609596 | Wnt/β-catenin signaling in bone marrow niche. |
| Q28269116 | Wnt/β-catenin signalling in prostate cancer |
| Q37025924 | Wnt/β-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours |
| Q26738408 | Wnt5a Signaling in Cancer |
| Q37991708 | β-Catenin Signalling in Glioblastoma Multiforme and Glioma-Initiating Cells |
| Q41828867 | β-catenin/Wnt signaling controls progenitor fate in the developing and regenerating zebrafish retina |
Search more.